Atlas Trials

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

Clinical trial NCT04188691 · COMPLETED

Trial details

NCT number
NCT04188691
Sponsor
National Vaccine and Serum Institute, China
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Norwalk GastroenteritisNorovirus Infections
Start date
2019-11-28
Primary completion
2020-12-13
Enrollment
510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.